Effect of a novel typhoid conjugate vaccine in Africa: a multicenter study in Ghana and the DRC Instituut voor Tropische Geneeskunde
of Experts in Q3/2017, typhoid conjugate vaccines (TCV) are now Gavi-subsidized. To date, one candidate, Typbar-TCV® (Bharat-Biotech, India), has successfully been licensed, solely on immunogenicity data, in several ...